Literature DB >> 16670528

Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD.

Sari Iltanen1, Laura Tervo, Tuula Halttunen, Bo Wei, Jonathan Braun, Immo Rantala, Teemu Honkanen, Mitchell Kronenberg, Hilde Cheroutre, Olga Turovskaya, Ville Autio, Merja Ashorn.   

Abstract

BACKGROUND: Bacteria are implicated as important factors in the pathogenesis of inflammatory bowel disease (IBD). The aim of this study was to seek evidence of possible bacterial targets of the immune response related to IBD in children.
METHODS: Seventy-eight children referred to the Department of Paediatrics at Tampere University Hospital on suspicion of IBD were included in the study. Upper and lower gastrointestinal endoscopies with biopsies were performed on all children. Sera from 75 children were tested for antibodies to the Pseudomonas fluorescens-associated sequence I2, a Bacteroides caccae TonB-linked outer membrane protein, OmpW, anti-Saccharomyces cerevisiae, and perinuclear anti-neutrophil cytoplasmic antibodies.
RESULTS: The IBD diagnosis was confirmed in 35 children (18 with Crohn's disease [CD], 12 with ulcerative colitis [UC], and 5 with indeterminate colitis [IC]); 43 children were found to have no inflammation in the gut. Forty-three percent (15 of 35) of those with IBD evinced positive seroreactivity to I2 and 46% (16 of 35) to OmpW. In CD, seroreactivity to I2 and OmpW was 50% (9 of 18) and 61% (11 of 18), respectively. Serum anti-I2 and anti-OmpW immunoglobulin A levels were significantly elevated in children with CD in comparison with the non-IBD group (P = 0.007 and P = 0.001, respectively). A combination of OmpW, I2, and anti-S cerevisiae tests identified 94% of CD patients, and a combination of OmpW, I2, and perinuclear anti-neutrophil cytoplasmic antibodies detected 83% of UC cases.
CONCLUSIONS: Among children with IBD, strong serological responses to microbial antigens can be found, suggesting that P fluorescens and B caccae antigens have a potential role in the microbiology and immunology of the disease. Furthermore, serologic reactivity to the set of antigens studied here seems to be applicable in the initial differential diagnosis of children with CD and UC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670528     DOI: 10.1097/01.MIB.0000218765.84087.42

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  17 in total

1.  Current and future role of serogenomics in ulcerative colitis.

Authors:  Mark H Flasar; Raymond K Cross; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

Review 2.  The status of diagnostic markers for inflammatory bowel disease.

Authors:  Poonam Beniwal; Laura Harrell
Journal:  Curr Gastroenterol Rep       Date:  2010-12

3.  Microbial Biomarkers in Patients with Nonresponsive Celiac Disease.

Authors:  Liisa Viitasalo; Kalle Kurppa; Merja Ashorn; Päivi Saavalainen; Heini Huhtala; Sara Ashorn; Markku Mäki; Tuire Ilus; Katri Kaukinen; Sari Iltanen
Journal:  Dig Dis Sci       Date:  2018-09-20       Impact factor: 3.199

Review 4.  Microbiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humans.

Authors:  Brittan S Scales; Robert P Dickson; John J LiPuma; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 5.  Evolving diagnostic strategies for inflammatory bowel disease.

Authors:  David H Bruining; Edward V Loftus
Journal:  Curr Gastroenterol Rep       Date:  2006-12

Review 6.  New serological markers in pediatric patients with inflammatory bowel disease.

Authors:  Márta Kovács; Katalin Eszter Müller; Mária Papp; Péter László Lakatos; Mihály Csöndes; Gábor Veres
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 7.  Diagnostic advances in inflammatory bowel disease (imaging and laboratory).

Authors:  Maria E Moscandrew; Edward V Loftus
Journal:  Curr Gastroenterol Rep       Date:  2009-12

8.  Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease.

Authors:  Sara Ashorn; Hanna Raukola; Tuuli Välineva; Merja Ashorn; Bo Wei; Jonathan Braun; Immo Rantala; Katri Kaukinen; Tiina Luukkaala; Pekka Collin; Markku Mäki; Sari Iltanen
Journal:  J Clin Immunol       Date:  2008-05-22       Impact factor: 8.317

9.  Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.

Authors:  Sara Ashorn; Teemu Honkanen; Kaija-Leena Kolho; Merja Ashorn; Tuuli Välineva; Bo Wei; Jonathan Braun; Immo Rantala; Tiina Luukkaala; Sari Iltanen
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

10.  Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.

Authors:  H Takedatsu; K D Taylor; L Mei; D P B McGovern; C J Landers; R Gonsky; Y Cong; E A Vasiliauskas; A Ippoliti; C O Elson; J I Rotter; S R Targan
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.